Lethal outcome of Covid-19 pneumonia in a new liver recipient with neurological manifestation
Gastroenterology and Hepatology from Bed to Bench,
,
20 September 2020
https://doi.org/10.22037/ghfbb.v13i4.2028
Abstract
Abstract
Covid-19 is a new contagious viral pneumonia with various signs and symptoms including, loss of consciousness, liver injury, and cerebrovascular accident, however, there are little data about manifestation and outcome of COVID-19 in the liver transplant patients. Also, according to the closing of transplant units in Iran from the first day of the COVID-19 pandemic, we don’t have accurate data about nosocomial COVID-19 and liver transplant settings. In this article, we introduced a liver transplant recipient with final fatal outcome, who have had neurological manifestation. and also COVID-19 manifestations were started within 2 days after transplant surgery in the hospital.
- COVID-19
- liver transplantation
References
Abdi M. Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems. Infect Control Hosp Epidemiol. 2020:1-2.
Moazzami B, Razavi-Khorasani N, Dooghaie Moghadam A, Farokhi E, Rezaei N. COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2020;126:104345-.
ORGANISATION WWH. Coronavirus disease (COVID-19) Situation Report– 110 2020 MAY 9 [Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200509covid-19-sitrep-110.pdf?sfvrsn=3b92992c_4.
Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281-6.
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology. 2020.
Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. The lancet Gastroenterology & hepatology. 2020;5(5):428-30.
Omrani-Nava V, Maleki I, Ahmadi A, Moosazadeh M, Hedayatizadeh-Omran A, Roozbeh F, et al. Evaluation of Hepatic Enzymes Changes and Association with Prognosis in COVID-19 Patients. Hepat Mon. 2020;20(4):e103179.
Saigal S, Gupta S, Sudhindran S, Goyal N, Rastogi A, Jacob M, et al. Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI). Hepatol Int. 2020:1-3.
Qin J, Wang H, Qin X, Zhang P, Zhu L, Cai J, et al. Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient. Hepatology (Baltimore, Md).n/a(n/a).
Tzedakis S, Jeddou H, Houssel-Debry P, Sulpice L, Boudjema K. COVID-19: Thoughts and comments from a tertiary liver transplant center in France. American Journal of Transplantation. 2020;n/a(n/a).
Bao C, Liu X, Zhang H, Li Y, Liu J. Coronavirus Disease 2019 (COVID-19) CT Findings: A Systematic Review and Meta-analysis. Journal of the American College of Radiology : JACR. 2020.
Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clinica chimica acta; international journal of clinical chemistry. 2020;506:145-8.
Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020:1-4.
Lippi G, Mattiuzzi C. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol Transfus Cell Ther. 2020:S2531-1379(20)30029-8.
Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020:S0889-1591(20)30685-1.
- Abstract Viewed: 0 times
